Literature DB >> 8344581

Serum carnitine concentrations in coeliac disease.

A Lerner1, N Gruener, T C Iancu.   

Abstract

Carnitine is essential for muscle energy production and is required for the transport of long chain fatty acids and acyl co-enzyme A derivatives across the inner mitochondrial membrane. Recently, an absorptive transport mechanism was discovered at the small bowel level suggesting the possibility of a carnitine deficient state in patients with mucosal damage. Therefore, this study investigated carnitine concentrations in serum of patients with coeliac disease. Serum samples were obtained from 12 patients with active coeliac disease and seven with non-active disease, and compared with serum samples of 17 children with gastrointestinal symptoms but with a small bowel normal on biopsy examination and 33 normal controls. Total serum carnitine concentration was significantly lower in the patients with coeliac disease compared with the other two groups and to reference values. When the degree of atrophy of coeliac intestinal mucosa was numerically graded, serum carnitine concentrations did not correlate to the degree of the intestinal lesion but were significantly lower in the damaged intestine compared with the group with normal mucosa. It is suggested that coeliac disease should be considered as a potential cause of secondary carnitine deficiency.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344581      PMCID: PMC1374228          DOI: 10.1136/gut.34.7.933

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Low blood and plasma carnitine levels in children receiving long-term parenteral nutrition.

Authors:  K A Dahlström; M E Ament; A Moukarzel; N E Vinton; G Cederblad
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-10       Impact factor: 2.839

2.  An improved and simplified radioisotopic assay for the determination of free and esterified carnitine.

Authors:  J D McGarry; D W Foster
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

Review 3.  The neurological manifestations of malabsorption.

Authors:  W T Cooke
Journal:  Postgrad Med J       Date:  1978-11       Impact factor: 2.401

4.  Myopathy as a presentation of coeliac disease.

Authors:  D Hardoff; B Sharf; A Berger
Journal:  Dev Med Child Neurol       Date:  1980-12       Impact factor: 5.449

Review 5.  Carnitine--metabolism and functions.

Authors:  J Bremer
Journal:  Physiol Rev       Date:  1983-10       Impact factor: 37.312

6.  Uptake of L-carnitine by rat jejunal brush border microvillous membrane vesicles. Evidence of passive diffusion.

Authors:  B U Li; P M Bummer; J W Hamilton; H Gudjonsson; G Zografi; W A Olsen
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

7.  Carnitine transport in human intestinal biopsy specimens. Demonstration of an active transport system.

Authors:  J W Hamilton; B U Li; A L Shug; W A Olsen
Journal:  Gastroenterology       Date:  1986-07       Impact factor: 22.682

8.  Celiac disease presenting as chronic hepatitis in a girl.

Authors:  G Maggiore; C De Giacomo; M S Scotta; F Sessa
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986 May-Jun       Impact factor: 2.839

9.  Plasma carnitine deficiency. Clinical observations in 51 pediatric patients.

Authors:  S C Winter; S Szabo-Aczel; C J Curry; H T Hutchinson; R Hogue; A Shug
Journal:  Am J Dis Child       Date:  1987-06

10.  Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport.

Authors:  L J Waber; D Valle; C Neill; S DiMauro; A Shug
Journal:  J Pediatr       Date:  1982-11       Impact factor: 4.406

View more
  11 in total

1.  Serum metabolomic profiles suggest influence of sex and oral contraceptive use.

Authors:  Margherita Ruoppolo; Ilaria Campesi; Emanuela Scolamiero; Rita Pecce; Marianna Caterino; Sara Cherchi; Giuseppe Mercuro; Giancarlo Tonolo; Flavia Franconi
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Serum prolactin in coeliac disease: a marker for disease activity.

Authors:  R Reifen; D Buskila; M Maislos; J Press; A Lerner
Journal:  Arch Dis Child       Date:  1997-08       Impact factor: 3.791

3.  Mapping of jvs (juvenile visceral steatosis) gene, which causes systemic carnitine deficiency in mice, on chromosome 11.

Authors:  H Nikaido; M Horiuchi; N Hashimoto; T Saheki; J Hayakawa
Journal:  Mamm Genome       Date:  1995-05       Impact factor: 2.957

4.  T cell receptor repertoire in the peripheral blood and intestinal mucosa of coeliac patients.

Authors:  N Lahat; A Ben-Nun; L Cohen; A Kinarty; A Lerner
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

5.  Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet.

Authors:  Judit Bene; Katalin Komlósi; Beáta Gasztonyi; Márk Juhász; Zsolt Tulassay; Béla Melegh
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

6.  Relative carnitine deficiency in autism.

Authors:  Pauline A Filipek; Jenifer Juranek; Minh T Nguyen; Christa Cummings; J Jay Gargus
Journal:  J Autism Dev Disord       Date:  2004-12

7.  ACG clinical guidelines: diagnosis and management of celiac disease.

Authors:  Alberto Rubio-Tapia; Ivor D Hill; Ciarán P Kelly; Audrey H Calderwood; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2013-04-23       Impact factor: 10.864

Review 8.  Thromboembolic complications and cardiovascular events associated with celiac disease.

Authors:  Fotios S Fousekis; Eleni T Beka; Ioannis V Mitselos; Haralampos Milionis; Dimitrios K Christodoulou
Journal:  Ir J Med Sci       Date:  2020-07-20       Impact factor: 1.568

Review 9.  Neurological complications of coeliac disease.

Authors:  D S N A Pengiran Tengah; A J Wills; G K T Holmes
Journal:  Postgrad Med J       Date:  2002-07       Impact factor: 2.401

10.  Environmental Enteric Dysfunction is Associated with Carnitine Deficiency and Altered Fatty Acid Oxidation.

Authors:  Richard D Semba; Indi Trehan; Ximin Li; Ruin Moaddel; M Isabel Ordiz; Kenneth M Maleta; Klaus Kraemer; Michelle Shardell; Luigi Ferrucci; Mark Manary
Journal:  EBioMedicine       Date:  2017-01-18       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.